The effect of salicylazosulphapyridine (sulphasalazine) on male fertility. A review
Open Access
- 1 February 1986
- journal article
- review article
- Published by Wiley in International Journal of Andrology
- Vol. 9 (1) , 38-52
- https://doi.org/10.1111/j.1365-2605.1986.tb00866.x
Abstract
Salicylazosulfapyridine (SASP), a drug used in the treatment of inflammatory bowel diseases, has been reported to depress the fertility in males. Therefore, some authors have proposed SASP as a new lead in the search for a contraceptive for men. Based on a review of the literature, our conclusion is that SASP taken in tolerable doses has not sufficient antifertility effect. Additionally, the drug has too serious and too many side effects to be accepted as a contraceptive. However, the effect on male fertility of other sulfa drugs and related compounds remains to be investigated.Keywords
This publication has 43 references indexed in Scilit:
- Abnormal Semen Quality and Low Serum Testosterone in Men with Inflammatory Bowel Disease Treated for a Long Time with Sulfasalazine*Andrologia, 2009
- SULPHASALAZINE: A ‘NEW’ ANTIRHEUMATIC DRUGRheumatology, 1984
- SulfasalazineDigestive Diseases and Sciences, 1983
- Drugs and sperm.BMJ, 1982
- Sulphasalazine and SpermatogenesisDigestion, 1982
- Incidence of sulphasalazine-induced male infertility.Gut, 1981
- Inhibition of Folate Enzymes by SulfasalazineJournal of Clinical Investigation, 1978
- Clinical Pharmacokinetics of SulphasalazineClinical Pharmacokinetics, 1976
- Hypertrophy of the testis induced by sulphadimidine and other pyrimidine derivativesProceedings of the Royal Society of London. B. Biological Sciences, 1952
- SULPHONAMIDES AND INFERTILITYThe Lancet, 1944